Newsfeeds - Spark Newswire

1 minute read

Rigel Pharmaceuticals Q3 EPS $(0.12) Misses $(0.10) Estimate, Sales $21.54M Miss $23.56M Estimate

Today, 5:36 PM

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent decrease over losses of $(0.08) per share from

RIGL

19 minute read

Earnings Scheduled For November 2, 2021

By Benzinga Insights

Today, 5:36 PM

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.

3 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 5:36 PM

BIOL

1 minute read

Rigel Stock Falls After Update From COVID-19 Program

By Vandana Singh

Today, 5:36 PM

The FDA has informed Rigel Pharmaceuticals Inc (NASDAQ:RIGL) that data submitted in May from fostamatinib Phase 2 trial for COVID-19…

RIGL

2 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 5:36 PM

ANIX

1 minute read

Rigel Pharmaceuticals Says FDA Informed Co. that Clinical Data Submitted In Late May From Phase 2 Trial Of Fostamatinib In COVID-19 Patients Are Insufficient For Emergency Use Authorization At This Time

By Bill Haddad

Today, 5:36 PM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that clinical data submitted in late-May from a 59-patient NIH/NHLBI-sponsored Phase 2

RIGL

2 minute read

Movers

Understanding Rigel Pharmaceuticals’s Unusual Options Activity

By Benzinga Insights

Today, 5:36 PM

Rigel Pharmaceuticals (NASDAQ:RIGL) shares experienced unusual options activity on Tuesday. The stock price moved up to $4.0 following the option alert.

RIGL

4 minute read

Options

10 Health Care Stocks Showing Unusual Options Activity In Today’s Session

By Benzinga Insights

Today, 5:36 PM

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

AMED

1 minute read

Rigel Pharmaceuticals Q2 EPS $(0.08) Beats $(0.11) Estimate, Sales $26.27M Beat $20.37M Estimate

By Benzinga Newsdesk

Today, 5:36 PM

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 20 percent increase over losses of $(0.10) per share

RIGL

6 minute read

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly’s Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business

By Shanthi Rexaline

Today, 5:36 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2)

ABSI